Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1)

Sozial- und Praventivmedizin

Volumn 47, Issue 6, 2002, Pages 408-426

  Azizi, Fereidoun ^a   Rahmani, Maziar ^a   Emami, Habib ^a   Mirmiran, P ^a   Hajipour, R ^a   Madjid, M ^a   Ghanbili, J ^a   Ghanbarian, A ^a   Mehrabi, Y ^a   Saadat, N ^a   Salehi, P ^a   Mortazavi, N ^a   Heydarian, P ^a   Sarbazi, N ^a   Allahverdian, S ^a   Saadati, N ^a   Ainy, E ^a   Moeini, S ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular disease; Diabetes mellitus; Dyslipoproteinemia; Hypertension; Risk factor

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CALORIC INTAKE; CARBOHYDRATE INTAKE; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLUSTER ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPOPROTEINEMIA; FAT INTAKE; FEMALE; HUMAN; HYPERTENSION; IRAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN INTAKE; RANDOMIZATION; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIET; ENERGY INTAKE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERLIPOPROTEINEMIAS; HYPERTENSION; IRAN; LIFE STYLE; LIPIDS; MALE; MARITAL STATUS; MIDDLE AGED; OBESITY; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; TRIGLYCERIDES; URBAN POPULATION;

EID: 0036919115     PISSN: 03038408     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000380200008     Document Type: Article

References (63)

1. Aguilera F, Lupianez L, Magana D, Planells E, Mataix FJ, Liopis J (1996). Lipid status in a population of Spanish schoolchildren. Eur J Epidemiol 12: 135-40.
2. Akerblom HK, Viikari J, Uhari M, et al. (1984). A study of cardiovascular risk factors and their determinats in finnish children. Ann Clin Res 16: 23-33.
3. Al-Nuaim AR, al-Rubean K, al-Mazrou Y, al-Attas O, al-Daghari (1996). Prevalence of hypercholesterolemia in Saudi Arabia, epidemiological Study. Int J Cardiol 54: 41-49.
4. Andersen LB, Henckel P, Saltin B (1989). Risk factors for cardiovascular disease in 16-19-year-old teenagers. J Int Med 225: 157-63.
5. Anonymous (1984a). The Lipid Research Clinics Coronary Primary Prevention Trial results II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251: 365-74.
6. Anonymous (1984b). The Lipid Research Clinics Coronary Prevention Trials results I: reduction in incidence of coronary heart disease. JAMA 251: 351-64.
7. Anonymous (1997). The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (published erratum appears in Arch Intern Med 1998; 158: 573). Arch Intern Med 157: 2413-46.
8. Azizi F (1996). Diabetes mellitus in Islamic Republic of Iran. IDF Bulletin 41: 38-39.
9. Azizi F, Rahmani M, Emami H, Madjid M (2000). Tehran Lipid and Glucose Study: Rationale and Design. CVD Prev 3: 242-7.
10. Azizi F, Rahmani M, Madjid M, et al. (2001). Serum lipid levels in an Iranian population of children and adolescents: Tehran Lipid and Glucose Study. Eur J Epidemiol 17: 281-88.
11. Azizi F, Allahverdian S, Mirmiran P, Rahmani M, Mohammadi M (2002). Dietary factors and body mass index in a group of Iranian adolescents: Tehran Lipid and Glucose Study-2. Int J Nutr Res 71: 123-27.
12. Beaglehole R, Stewart AW, Jackson R, et al. (1997). Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993. Am J Epidemiol 145: 707-13.
13. Boreham C, Savage JM, Primrose D, Strain J (1993). Coronary risk factors in schoolchildren. Arch Dis Child 68: 182-86.
14. Campos H, Willet WC, Peterson RM, et al. (1991). Nutrient intake comparisons between Framingham and rural and utban Puriscal, Costa Rica: association with Lipids, lipoproteins, apolipoproteins and LDL particle size. Arteriosclerosis 11: 1089-99.
15. Castelli WP (1986). The Triglycerides issue: a viwe from Framingham. Am Heart J 112: 432-37.
16. CDC (1997). Prevalence of selected cardiovascular disease risk factors among American Indians and Alaska Natives-United States. MMWR 2000; 49: 461-65.
17. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000). Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320: 1240-43.
18. Dowse G, Zimmet P (1992). A model protocol for diabetes and other noncommunicable disease field surveys. World Health Stat Q 45: 360-72.
19. Food and Nutrition Board, National Research Council, National Academy of Sciences (1989). Recommended dietary allowances. 10th ed, Washington: National Academy Press.
20. Franklin FA, Dashti N, Franklin CC (1998). Evaluation and management of dyslipoproteinemia in children. Endocrinol Metabol Clin North Am 27: 641-54.
21. Friedwald WT, Levy RI, Fredridson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
22. Garaulet M, Martinez A, Victoria F, Perez-Llamas F, Ortega RM, Zamora S (2000). Difference in dietary intake and activity level between normal-weight and over weight or obese adolescents. J Pediatr Gastroenterol Nutr 30: 253-58.
23. Gidding S (1995). A perspective on obesity. Am J Med Sci 310: 68-71.
24. Gliksman MD, Lazarus R, Wilson A (1993). Differences in serum lipids in Australian children: is diet responsible? Int J Epidemiol 22: 247-54.
25. Hall WD, Ferrario CM, Moore MA, et al. (1997) Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci 313: 195-209.
26. Harsha DW (1995). The benefits of physical activity in childhood. Am J Med Sci 310: 3-7.
27. Hayes KC (1995). Saturated fat and blood lipids: new slant on an old story. Can J Cardiol 11: 39-46.
28. Hegsted DM, Ausman L, Johnson J, Dallas G (1993). Dietary fat and serum lipids: An evaluation of the experimental data. Am J Clin Nutr 57: 875-83.
29. Hirvonen T, Mannisto S, Roos E, Pietinen P (1997). Increasing prevalence of underreporting does not necessarily distort dietary surveys. Eur J Clin Nutr 51: 297-301.
30. Hutchinson RG, Watson RL, Davis CE, et al. (1997). Racial differences in risk factors for atherosclerosis, the ARIC study. Angiology 48: 279-90.
31. Lauer RM, Connor WE, Leaverton PE, Reiter MA, Clarke WR (1975). Coronary heart disease risk factors in school children: the Muscatine Study. J Pediatr 86: 697-706.
32. Lenfant C, Savage P (1995). The early natural history of atherosclerosis and hypertension in the young: National Institute of Health Perspectives. Am J Med Sci 310: 3-7.
33. Lewis CE, Smith DE, Wallace DD, Williams OD, Bild DE, Jacobs DR Jr (1997). Seven year trends in weight and weight gain in black and white young adults: The CARDIA Study. Am J Public Health 87: 635-42.
34. McGill HC, McMahan CA, Malcom GT, Oalmann Mc, Strong JP (1997). Effects of serum lipoproteins and smoking on atherosclerosis in young men and women, the PADY Research Group: pathobiological determinants of atherosclerosis in youth. Arterioscler Thromb Vasc Biol 17: 95-106.
35. Maclean DR, Petrasovits A, Connelly PW, Joffres M, O'Connor B, Little JA (1996). Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. Can J Cardiol 15: 434-44.
36. Monge R, Beita O (2000). Prevalence of coronary heart disease risk factors in costa rican adolescents. J Adoles Health 27: 210-17.
37. Murray CJL, Lopez AD (1997). Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349: 1269-76.
38. National High Blood Pressure Education Program Working Group on Hypertension Control in children and Adolescents (1996). Update on 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A Working Group Report on High Blood Pressure Education Program. Pediatrics 98: 649-58.
39. Newman WP 3rd, Freedman DS, Voors AW, et al. (1986). Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: The Bugalusa Heart Study. N Engl J Med 314: 138-44.
40. O'Connor G, Hennekens C, Willett WC, et al. (1995). Physical exercise and reduced risk of non fatal myocardial infarction. Am J Epidemiol 12: 1147-52.
41. Plaza I, Mariscal RP, Ros-Jellici J, et al. (1989). The Fuenlabrada Study: lipids and lipoproteins in children and adolescents. Rev Esp Cardiol 42: 444-48.
42. Rabbia F, Veglio F, Pinna G, et al. (1994). Cardiovascular risk factors in adolescents: prevalence and familial aggregation. Prev Med 23: 809-15.
43. Rafei M, Boshtam M, Sarafzadegan N (1999). Lipid Profiles in the Isfahan population: an Isfahan cardiovascular disease risk factor survey, 1994. EMHJ 5: 766-77.
44. Raftopoulos C, Bermingham MA, Steinbeck KS (1999). Coronary heart disease risk factors in male adolescents, with particular reference to smoking and blood lipids. J Adoles Health 25: 68-74.
45. Sempos C, Cooper R, Kovar MG, McMillen M (1988). Divergence of the recent trends in coronary mortality for the four major race-sex group in the United States. Am J Public Health 78: 1422-27.
46. Sempos CT, Cleeman JI, Carroll MD, et al. (1993). Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National cholesterol Education Program Adult Treatment Panel. JAMA 269: 3009-14.
47. Sempos CT, Bild DE, Manolio TA (1999). Overview of the Jackson Heart Study: a study of cardiovascular diseases in African American Men and Women. Am J Med Sci 317: 142-46.
48. Singh RB, Rastogi V, Niaz MA, Ghosh S, Sy RG, Janus ED (1998). Serum cholesterol and coronary artery disease in populations with low cholesterol levels: The Indian Paradox. Int J Cardiol 65: 81-90.
49. Stamler J (1978). George lyman Duff Memorial Lecture: lifestyles, major risk factors, proof, and public policy. Circulation 58: 3-19.
50. Stamler J, Dyer AR, Shekelle RD, Neaton J, Stamler R (1993). Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long term follow-up of Chicago cohorts. Cardiology 82: 222.
51. Stray HC (1989). Evolution and progression of atherosclerosis lesions in coronary arteries of children and young adults. Artheriosclerosis 9: 19-32.
52. Strong JP (1991). The Natural history of atherosclerosis in childhood. Ann N Y Acad Sci 623: 9-15.
53. Sytkowski PA, Agostino RB, Belanger A, Kannel WB (1996). Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol 143: 338-50.
54. Uemura K, Pisa Z (1985). Recent trends in cardiovascular disease mortality in 27 industrialized countries. World Health Stat Q 38: 142-42.
55. US Department of Health and Human Services, Public Health Service (1992). National Cholesterol Education Program: highlights of the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. National Institutes of Health, National Heart, Lung, and Blood Institute. J Am Osteopath Assoc 92: 380-88.
56. Vobecky JS, David P, Vobecky J (1988). Identification of risk factors of hypercholesterolemia in children: 9 year follow-up. Rev Epidemiol Sante Publique 36: 409-20.
57. Webber L, Waftigney W, Srinivasan S, Berenson G (1995). Obesity studies in Buglusa. Am J Med Sci 310: 53-61.
58. World Health Organization (1985). Diabetes Mellitus: report of a WHO Study Group. Geneva: World Health Organization: Tech Rep. Ser. No 727.
59. World Health Organization (1990). MONICA manual. Geneva: WHO
60. World Health Organization, Eastern Mediterranean Regional Office (1995). Prevention and control of cardiovascular diseases. Alexandria: WHO-EMRO: 24.
61. World Health Organization (1998). Guideline for controlling and monitoring. The Tobacco Epidemic. Geneva.
62. Yusuf HR, Giles WH, Groft JB, Anda RF, Casper ML (1988). Impact of multiple risk factor profiles on determining cardiovascular disease risk. Prev Med 27: 1-9.
63. Zali M, Kazem M, Masjedi MR (1993). Health and disease in Iran. Deputy of Research, Ministry of Health. Bulletin No. 10. (In Farsi)